Cadonilimab Combination Regimen as First-line Treatment for HER2-expressing GC/GEJ Patients
Clinical trial NCT06650332 · RECRUITING
Trial details
- NCT number
- NCT06650332
- Sponsor
- Zhejiang Cancer Hospital
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-10
- Primary completion
- 2026-08-10
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.